Stay updated with breaking news from Debanjan Ray. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BOSTON & WEST HAVEN, Conn.--(BUSINESS WIRE)--Normunity, Inc., a biotechnology company creating novel precision anti-cancer immunotherapies, today announced the appointment of Debanjan Ray, MBA, to its board of directors. Mr. Ray currently serves as President and Chief Executive Officer of Synthekine, and he has serv...
Published: Feb 04, 2021 MENLO PARK, Calif.--(BUSINESS WIRE)-- Synthekine Inc., an engineered cytokine therapeutics company, today announced that it has appointed Pablo Cagnoni, M.D., to its board of directors. Dr. Cagnoni brings to Synthekine extensive leadership experience in the biotech industry and a successful track record of oncology drug development. The company also announced the formation of its scientific advisory board to help guide the company’s extensive cytokine engineering efforts. “Synthekine has made significant advances in 2020, with our first programs on track...